Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.

Saved in:
Bibliographic Details
Title: Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Authors: Vose JM; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Ganguly S; University of Kansas Cancer Center, Westwood, Kansas, USA.; Houston Methodist Hospital and Neal Cancer Center, Houston, Texas, USA., Bierman PJ; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Bociek RG; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Lunning M; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Lyden L; College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA., Meza JL; College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA., Caimi PF; University Hospital Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA., Armitage JO; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Source: British journal of haematology [Br J Haematol] 2023 Jul; Vol. 202 (1), pp. 116-121. Date of Electronic Publication: 2023 Apr 25.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first